Mary Ann Liebert, Inc. is a global media company dedicated to creating, curating, and delivering impactful peer-reviewed research and authoritative content services to advance the fields of biotechnology and the life sciences, specialized clinical medicine, and public health and policy.
We believe that specialist information powers better research, productivity, and outcomes, and since our founding in 1980, we have focused on identifying areas of the greatest need in the fields we serve. Today, our exceptional educational content and technology-enabled services inform leading researchers and clinicians around the globe, equip them with the tools and applications to make a difference in the lives of others, and enable them to make the next great scientific and medical breakthroughs.
As a leader in the Open Access movement, Mary Ann Liebert, Inc. supports and encourages open science for researchers, institutions, and funders, and we are fully compliant with the Open Access policies from all major funders and institutions. We deliver a publishing experience that is unrivaled in the market and that recognizes and values our authors’ hard work and ensures the greatest impact for their content for the long-term.
By committing to the things that matter – speed, quality, access, and exposure – combining personal attention with leading technology-enabled capabilities, we rapidly publish and amplify content that is found and accessible in leading institutions across the globe.